You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,288,095


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,288,095
Patent landscape, scope, and claims:
Title: Compounds
Abstract:A method is provided for the treatment and/or prophylaxis of cardiovascular diseases or eating disorders in a human or non-human mammal, which comprises administering to a human or non-human mammal in need thereof, an effective, non-toxic amount of a compound of formula (I): ##STR1## or a tautomeric form thereof and/or a pharmaceuticlaly acceptable salt thereof and/or a pharmaceutically acceptable solvate thereof, in which A.sup.1 represents a substituted or unsubstituted aromatic heterocyclyl group; R.sup.1 represents a hydrogen atom, an alkyl group, an acyl group, an aralkyl group, wherein the aryl moiety may be substituted or unsubstituted, or a substituted or unsubstituted aryl group; R.sup.2 and R.sup.3 each represent hydrogen, or R.sup.2 and R.sup.3 together represent a bond; A.sup.2 represents a benzene ring having in total up to five substituents; and n represents an integer in the range of from 2 to 6.
Inventor(s): Hindley; Richard Mark (Epsom, GB), Cawthorne; Michael Antony (Epsom, GB)
Assignee: Beecham Group p.l.c. (GB)
Application Number:08/358,327
Patent Claim Types:
see list of patent claims
Use; Composition; Process; Dosage form;

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,288,095

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,288,095

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8720825Sep 04, 1987
United Kingdom8727987Nov 30, 1987
United Kingdom8802454Feb 04, 1988

International Family Members for US Patent 6,288,095

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0306228 ⤷  Subscribe SPC/GB01/002 United Kingdom ⤷  Subscribe
European Patent Office 0306228 ⤷  Subscribe 2001C/004 Belgium ⤷  Subscribe
European Patent Office 0306228 ⤷  Subscribe C300034 Netherlands ⤷  Subscribe
European Patent Office 0306228 ⤷  Subscribe 38/2000 Austria ⤷  Subscribe
Austria 186724 ⤷  Subscribe
Australia 2173888 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.